Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
82
-
Total 13F shares, excl. options
-
61.5M
-
Shares change
-
+27.9M
-
Total reported value, excl. options
-
$198M
-
Value change
-
+$89.3M
-
Put/Call ratio
-
0.16
-
Number of buys
-
55
-
Number of sells
-
-25
-
Price
-
$3.22
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q2 2019
99 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q2 2019.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61.5M shares
of 170M outstanding shares and own 36.09% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (21.6M shares), FMR LLC (8.1M shares), ARK Investment Management LLC (7.04M shares), Sumitomo Mitsui Trust Holdings, Inc. (4.84M shares), Nikko Asset Management Americas, Inc. (4.84M shares), PERCEPTIVE ADVISORS LLC (2.5M shares), BlackRock Inc. (2.32M shares), VANGUARD GROUP INC (2.06M shares), RENAISSANCE TECHNOLOGIES LLC (1.04M shares), and Marshall Wace North America L.P. (973K shares).
This table shows the top 82 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.